Should a patient who has been on Adderall XR 30 mg daily, Adderall IR 30 mg twice daily for two months, and a trial of Vyvanse, reduce the Adderall dose to a starting dose of 5 mg immediate‑release?

Dose Reduction to 5 mg IR Adderall: Not Recommended After High-Dose Exposure

After two months on very high doses (Adderall XR 30 mg daily plus Adderall IR 30 mg twice daily = 90 mg total daily), reducing directly to 5 mg IR is not advisable and represents an inappropriately abrupt taper that risks withdrawal symptoms and loss of symptom control. 1

Why This Approach Is Problematic

Magnitude of Dose Reduction

• You are proposing a reduction from 90 mg total daily dose to 5 mg daily—a 94% reduction in a single step 2
• This represents dropping from 3× the maximum recommended daily dose (40 mg for amphetamines per PDR guidelines) to well below therapeutic levels 1
• The FDA-approved starting dose of 5 mg is intended for treatment-naïve patients, not those with established tolerance to high doses 2

Appropriate Tapering Strategy

A gradual dose reduction is essential to minimize withdrawal effects and maintain some degree of symptom control during the taper. 1

• Initial reduction: Decrease by 10-25% of the current total daily dose every 1-2 weeks 1
• From 90 mg daily, this means reducing to approximately 70-80 mg initially, not 5 mg
• Continue stepwise reductions of 5-10 mg every 1-2 weeks until reaching the target dose 1
• Monitor for withdrawal symptoms (fatigue, depression, increased appetite, hypersomnia) and ADHD symptom recurrence at each step 1

Clinical Considerations

If Complete Discontinuation Is the Goal

• Taper over 4-8 weeks minimum given the high baseline dose 1
• Consider switching to a longer-acting formulation during taper to smooth the transition 3
• Implement behavioral interventions and psychosocial supports during the taper period 1

If Restarting at Lower Therapeutic Dose

• After complete washout (3-5 days), restart at 10 mg daily (not 5 mg) for adults per FDA guidelines 2
• The 5 mg starting dose is primarily for children when clinicians judge a lower initial dose appropriate 2
• Titrate by 5-10 mg weekly increments based on response 1

Red Flags to Monitor

• Rebound ADHD symptoms may be severe given the high previous dose 1
• Withdrawal dysphoria and fatigue are common with abrupt amphetamine discontinuation 1
• Cardiovascular parameters (blood pressure, heart rate) should be monitored during taper 1

Alternative Approach

Consider a structured taper protocol:

1. Week 1-2: Reduce to 60 mg daily (30 mg XR + 15 mg IR twice daily) 1
2. Week 3-4: Reduce to 40 mg daily (20 mg XR + 10 mg IR twice daily) 1
3. Week 5-6: Reduce to 20 mg daily (20 mg XR or 10 mg IR twice daily) 1
4. Week 7-8: Reduce to 10 mg daily if continuing treatment, or discontinue 2

The key principle: gradual dose reduction prevents withdrawal symptoms while allowing assessment of the minimum effective dose needed for symptom control. 1